Halaman 3 - Imunoterapi dengan Keytruda (Pembrolizumab) Dokter Terbaik - TOP-68 dokter

Profesor Madya Muhammed Mustafa Atci berspesialisasi dalam onkologi medis di Rumah Sakit Liv Topkapı Universitas İstinye, dengan fokus kuat pada pengobatan imunoterapi.

• Anggota Masyarakat Onkologi Klinis Amerika (ASCO)
• Telah menerbitkan banyak artikel yang ditinjau sejawat tentang hasil pengobatan kanker
• Koordinator Pendidikan untuk Sub-Cabang Onkologi Medis
• Pengalaman luas dalam mengobati berbagai jenis kanker dengan imunoterapi

Assoc. Prof. Ayşe İrem Yasin, M.D., is a medical oncologist who specializes in solid tumors. Her clinical focus includes breast, lung, gastrointestinal, gynecologic, and urologic cancers. She also treats brain and other CNS tumors, soft tissue sarcomas, head and neck cancers, adenocarcinomas, melanoma, Merkel cell carcinoma, and cancers of unknown primary. She practices at Medipol Acıbadem District Hospital (2025–present). She previously worked at Şişli Etfal Training and Research Hospital (2023–2025).

She completed a Medical Oncology fellowship at Bezmialem Vakıf University (2019–2022). This followed an Internal Medicine residency at the same institution (2012–2016). Her international experience includes the Breast Cancer Unit at the University of Piemonte Orientale in Novara (2022). She also trained at Basel University Hospital, Cleveland Clinic, and Harvard Medical School. She holds the ESMO Board Certificate (2022).

Dr. Maha Yahia is a medical oncologist and hemato-oncologist. She provides assessment, diagnosis, and treatment planning. Her treatments include chemotherapy, targeted therapy, and immunotherapy. She cares for patients with breast, genitourinary, gynecologic, thoracic, gastrointestinal, and rare cancers.

Education: M.B.B.Ch, Kasr El-Aini, Cairo University (1997–2003). Master in Hemato-oncology, National Cancer Institute, Cairo University (2008). Doctoral Degree in Hemato-oncology, National Cancer Institute, Cairo University (2015).

Experience: Resident in Medical Oncology, Maadi AFMC (2005–2010). Visitor Resident, NCI Cairo (2008–2009). Consultant Assistant, Prof. Hussein Khaled Clinic (2010–2017). Specialist, International Medical Center (2011–2012), Wadi El Nile Hospital (2013–2014), and Maadi AFMC (2011–2018). Head, Clinical Research Support Team, Maadi AFMC (2016–2018). Major (2014–2016) and Lt. Colonel Doctor (2016–2018), Egyptian Armed Forces. Lecturer of Clinical Research, AFCM (2019–2021).

Dr. Emad Shash, M.B.B.Ch, MSc, M.D., is a medical oncologist. He is the Medical Director of the Breast Comprehensive Cancer Hospital at NCI. He leads the Medical Oncology Department and is the Breast Program Director at Shifaa Al Orman Cancer Hospital in Luxor. His clinical focus includes breast, gynecologic, genitourinary, thoracic, gastrointestinal, and rare cancers. He specializes in systemic therapy, including chemotherapy, targeted therapy, and immunotherapy.

He served as coordinating research physician and medical lead at the EORTC from 2011 to 2015. Since 2008, he has contributed to more than 70 international oncology trials as a coordinator, sub-investigator, principal investigator, and sponsor medical monitor. Credentials include M.B.B.Ch (2004), MSc (2010), MD (2015), and the EORTC Certificate of Excellence (2015). He also holds a Diploma in Hospital Quality Management & Patient Safety (JCI/57357, 2017). He is a Fellow of the EIO. He is a member of ESMO (panel voting), ESGO, and ASCO (IAC), and serves on the ECRIN board.

Professor Raanan Berger, MD PhD, is a medical oncologist and radiotherapist. He is Director of the Cancer Center at Sheba Medical Center and heads its clinical research unit. He was listed in Forbes Israel’s “Best Doctors” (2025). He leads the genitourinary oncology program with a focus on prostate cancer. His care includes systemic therapy and radiotherapy in a multidisciplinary, patient-centered model.

He is board-certified in oncology. He earned his MD and PhD at Tel Aviv University and completed his clinical training at Sheba. He then completed a postdoctoral fellowship at Dana-Farber/Harvard, focusing on prostate cancer with Dr. Philip Kantoff and molecular oncology in Dr. William C. Hahn’s lab. He is a member of ESMO and ASCO. He has co-authored more than 20 peer-reviewed papers, including studies on outcomes in high- versus very high-risk prostate cancer and on BRCA1/2 in large cohorts.

Professor Jair Bar, MD, PhD, is a thoracic oncologist and Deputy Director of the Cancer Center at Sheba Medical Center. He leads the Thoracic Oncology Unit. He treats lung cancer, including advanced non-small cell cases. His care includes medical oncology, radiotherapy, immunotherapy, and targeted therapy.

He runs a translational research lab focused on resistance to immunotherapy. He has published on exhaled-breath cancer metabolism and on angiogenesis inhibition in lung cancer.

He has chaired the Israel Lung Cancer Group since 2003. He is a member of the Israel Society of Clinical Oncology and Radiotherapy, the American Society of Clinical Oncology, and the American Association for Cancer Research. He is board-certified in Medical Oncology and Radiotherapy Oncology. He is a Senior Lecturer at Tel Aviv University.

Dr. Eytan Aharon Ben‑Ami, MD, is a Senior Physician in the Sarcoma and Bone Oncology Service at Sheba Medical Center. He heads the Oncology Division and the Early-Phase Clinical Trials Unit. He founded the Sheba Clinical Research Organization. He is an academic affiliate at Tel Aviv University.

He specializes in sarcomas and primary bone tumors, including soft tissue sarcoma, liposarcoma, leiomyosarcoma, and osteosarcoma. He leads Phase I trials in targeted therapy and immunotherapy. He designs personalized treatment plans for rare cancers. He also develops patient-centered programs, including pilots in advanced immunotherapy delivery.

He completed a fellowship in Sarcoma and Bone Oncology at the Dana-Farber Cancer Institute/Harvard Cancer Center. He has authored more than 40 publications on early detection, molecular and viral mechanisms, and new cancer therapies.

Profesor Bosch memimpin penelitian global mengenai Leukemia Limfositik Kronis (LLK) dan pengobatan limfoma, dengan lebih dari 80 uji klinis yang aktif.

• Berspesialisasi dalam limfoma dan LLK di Rumah Sakit Quiron Barcelona
• Telah memublikasikan lebih dari 100 artikel di jurnal terkemuka seperti NEJM dan Nature Medicine
• Kepala Hematologi di Rumah Sakit Universitas Vall d'Hebron
• Mengembangkan pendekatan terapeutik baru untuk gangguan limfoproliferatif

Spesialis terkemuka Israel dalam imunoterapi kanker paru-paru – Prof. Peled memimpin Unit Kanker Toraks di Pusat Kanker Davidoff.

• Pakar dalam Ilmu Penyakit Dalam, Pulmonologi, dan Onkologi Medis
• Penerima penghargaan ASCO MERIT untuk penelitian yang luar biasa
• Kepala Unit Penelitian dan Deteksi untuk Keganasan Toraks di Sheba Medical Center
• Ketua Komite Deteksi Dini & Pencegahan IASLC

Wakil Kepala Departemen Onkologi di Pusat Medis Rambam – Dr. Bar-Sela berspesialisasi dalam perawatan kanker mutakhir.

• Pakar imunoterapi dengan Keytruda (pembrolizumab)
• Fokus pada rencana perawatan kanker yang dipersonalisasi
• Bekerja di departemen onkologi terkemuka di Israel

Dokter Kepala Pusat Onkologi di Assuta Medical Center, berspesialisasi dalam pengobatan imunoterapi.

• Dokter Onkologi dengan pengalaman luas dalam terapi target
• Memimpin tim khusus untuk pengobatan kanker lanjutan
• Berfokus pada rencana perawatan yang dipersonalisasi untuk pasien

Prof. Dr. Serdar Bedii Omay memiliki lebih dari 65 artikel ilmiah di bidang hematologi dan transplantasi sumsum tulang, serta pengalaman penelitian internasional yang luas.

• Berspesialisasi dalam hematologi dengan gelar PhD dari Mie Medical School, Jepang
• Profesor di Ege University dan Karadeniz Technical University
• Lebih dari 34 presentasi konferensi di bidang tersebut

Prof. Baytan berspesialisasi dalam kanker masa kanak-kanak dan hematologi, dengan pengalaman yang luas dalam perawatan leukemia dan limfoma.

• Lulus dari Fakultas Kedokteran Universitas Ankara
• Menerbitkan 15 artikel di jurnal internasional
• Berspesialisasi dalam perawatan kekurangan zat besi dan kekurangan vitamin
• Bekerja di Rumah Sakit Emsey

Prof. Osman Ilhan memelopori transplantasi sel punca sumsum tulang pertama di Turki dan berlatih di MD Anderson Cancer Center. Sekarang memimpin di Koru Ankara Hospital, beliau membawa keahlian hematologi lebih dari 45 tahun.

• Berspesialisasi dalam imunoterapi dan terapi sel punca untuk kanker darah
• Presiden pendiri Asosiasi Terapi Seluler dan Kedokteran Regeneratif
• Pemegang empat paten medis termasuk penelitian sel punca kanker
• Bersertifikat CME Platinum oleh Asosiasi Hematologi Eropa
• 300+ publikasi PubMed dengan lebih dari 5.000 kutipan

Dr. Lalit telah melakukan lebih dari 10.000 operasi besar, berspesialisasi dalam kanker gastrointestinal dan teknik bedah minimal invasif.

• 10 tahun pengalaman bedah dengan hasil yang sangat baik
• Pelatihan fellowship di Tata Medical Centre, pemimpin dalam onkologi
• Co-principal investigator dalam berbagai studi penelitian kanker
• Fokus khusus pada kanker gastrointestinal
• Diterbitkan di jurnal nasional dan internasional

Kepala Pulmonologi di Klinik Bremen-Ost, tempat 500+ pasien kanker paru-paru menerima imunoterapi setiap tahun. Berspesialisasi dalam pengobatan Keytruda (Pembrolizumab).

• Memimpin pusat perawatan kanker paru-paru bersertifikat
• Penulis berbagai makalah tentang penyakit pernapasan
• Anggota Masyarakat Pulmonologi Jerman
• Berspesialisasi dalam kanker paru-paru dan masalah pernapasan terkait tidur

Dr. Girish Badarkhe berspesialisasi dalam mengobati kanker darah dengan imunoterapi di HCG Manavata Cancer Centre, menawarkan lebih dari 13 tahun keahlian terfokus.

• Terlatih dalam Hematologi Klinis di Medical College, Calcutta
• Spesialisasi dalam leukemia, mieloma multipel, dan transplantasi sumsum tulang
• Penerima penghargaan atas profesionalisme dan kerja keras
• Menggunakan protokol imunoterapi canggih termasuk Keytruda

Dr. Shaunak mempresentasikan penelitian tentang kanker lambung di simposium American Society of Clinical Oncology – sebuah kehormatan langka bagi ahli onkologi muda.

• Spesialisasi dalam perawatan kanker berbasis molekuler dan terapi target
• Terlatih DNB dalam Onkologi Medis dari Rumah Sakit Indraprastha Apollo
• Memberi kuliah di International Winter School of Oncology di AIIMS
• Mantan Registrar di Rumah Sakit Kanker Jawaharlal Nehru

Dr. Ahmer Arif Shaikh berspesialisasi dalam pengobatan kanker mulut dan rehabilitasi fungsional di HCG Manavata Cancer Centre.

• 3 tahun pengalaman di Onkologi Bedah
• Ahli dalam kanker mulut, preservasi organ, dan rehabilitasi fungsional
• Mahir dalam operasi maksilofasial dan kepala & leher utama
• Pelatihan beasiswa (Fellowship) dalam Onkologi Bedah Kepala & Leher
• Peneliti aktif dengan banyak publikasi